168 related articles for article (PubMed ID: 23784265)
1. Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR; Shafiei N; Safarinejad S
Urolithiasis; 2013 Aug; 41(4):303-13. PubMed ID: 23784265
[TBL] [Abstract][Full Text] [Related]
2. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy.
Kaleta B; Krata N; Zagożdżon R; Mucha K
Cells; 2019 May; 8(6):. PubMed ID: 31159229
[TBL] [Abstract][Full Text] [Related]
5. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
[TBL] [Abstract][Full Text] [Related]
6. SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility.
Chen LZ; He CY; Su X; Peng JL; Chen DL; Ye Z; Yang DD; Wang ZX; Wang F; Shao JY; Xu RH
Gene; 2018 Jan; 640():43-50. PubMed ID: 28962925
[TBL] [Abstract][Full Text] [Related]
7. Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene.
Gazal S; Sacre K; Allanore Y; Teruel M; Goodall AH; ; Tohma S; Alfredsson L; Okada Y; Xie G; Constantin A; Balsa A; Kawasaki A; Nicaise P; Amos C; Rodriguez-Rodriguez L; Chiocchia G; Boileau C; Zhang J; Vittecoq O; Barnetche T; Gonzalez Gay MA; Furukawa H; Cantagrel A; Le Loët X; Sumida T; Hurtado-Nedelec M; Richez C; Chollet-Martin S; Schaeverbeke T; Combe B; Khoryati L; Coustet B; El-Benna J; Siminovitch K; Plenge R; Padyukov L; Martin J; Tsuchiya N; Dieudé P
Ann Rheum Dis; 2015 Mar; 74(3):e19. PubMed ID: 24448344
[TBL] [Abstract][Full Text] [Related]
8. SPP1 gene polymorphisms associated with nephrolithiasis in Turkish pediatric patients.
Tekin G; Ertan P; Horasan G; Berdeli A
Urol J; 2012; 9(4):640-7. PubMed ID: 23235966
[TBL] [Abstract][Full Text] [Related]
9. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma.
Fan Y; Zhang X; Yang ZH; Sun XW; Li SN; Zhong L; Cheng X; Wang Y; Ma YR
DNA Cell Biol; 2013 Oct; 32(10):594-600. PubMed ID: 23952692
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between osteopontin gene genetic polymorphisms and susceptibility of nasopharyngeal carcinoma in Guangxi Zhuang people].
Wei G; Yang F; Liang L; Liang L; Wei C; Luo B; Wei Y; Nong L; Tang Y; Wang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 50(2):127-30. PubMed ID: 25916533
[TBL] [Abstract][Full Text] [Related]
11. The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort.
Cambray S; Galimudi RK; Bozic M; Bermúdez-López M; Rodríguez I; Valdivielso JM
J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31036794
[TBL] [Abstract][Full Text] [Related]
12. Association of Osteopontin Gene Polymorphisms with Colorectal Cancer.
Kamal A; Darwish RK; Saad S; Salama M; El-Baradie TS; Mahmoud HG; Elshiwy Y
Cancer Invest; 2017 Feb; 35(2):71-77. PubMed ID: 28095066
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.
Zhao Y; Zhang L; Mao Z; Zhang Y; Su X; Cao Y; Tang P
Med Sci Monit; 2015 Dec; 21():3875-9. PubMed ID: 26656246
[TBL] [Abstract][Full Text] [Related]
14. Phosphoprotein 1 (osteopontin) gene (rs4754) affects markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus.
Pleskovič A; Šantl Letonja M; Cokan Vujkovac A; Makuc J; Nikolajević Starčević J; Petrovič D
Int Angiol; 2018 Feb; 37(1):64-70. PubMed ID: 28990744
[TBL] [Abstract][Full Text] [Related]
15. Association of osteopontin gene haplotypes with nephrolithiasis.
Gao B; Yasui T; Itoh Y; Li Z; Okada A; Tozawa K; Hayashi Y; Kohri K
Kidney Int; 2007 Sep; 72(5):592-8. PubMed ID: 17519954
[TBL] [Abstract][Full Text] [Related]
16. The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.
Lavi H; Assayag M; Schwartz A; Arish N; Fridlender ZG; Berkman N
PLoS One; 2017; 12(3):e0171945. PubMed ID: 28253271
[TBL] [Abstract][Full Text] [Related]
17. Association between
Xiao X; Dong Z; Ye X; Yan Y; Chen X; Pan Q; Xie Y; Xie J; Wang Q; Yuan Q
Biomed Rep; 2016 Sep; 5(3):321-326. PubMed ID: 27602211
[TBL] [Abstract][Full Text] [Related]
18. SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease.
Patel YP; Patel SG; Patel SB; Parikh A; Soni S; Srivastava R; Raval C; Raval MA; Nand Pandey S; Ganpule AP; Desai MR
Gene; 2023 May; 863():147264. PubMed ID: 36804854
[TBL] [Abstract][Full Text] [Related]
19. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
20. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
